MYCN and neuroblastoma: A confounding bias was unlikely in the reanalysis of the dataset of patients affected by Stage 4S neuroblastoma because the analysed patients were quite homogeneous for the major known prognostic factors, including age at diagnosis, stage, and amplification of the MYCN proto-oncogene.